| Richard B Weininger, MD | |
|
125 Millbrook Road, Hudson, NY 12534 | |
| (914) 388-0800 | |
| (518) 751-1531 |
| Full Name | Richard B Weininger |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Hematology & Oncology |
| Location | 125 Millbrook Road, Hudson, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013244185 | NPI | - | NPPES |
| 117078 | Other | NY | STATE LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 117078 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Richard B Weininger, MD P.o Box 737, 125 Millbrook Rd., Claverack, NY 12513 Ph: (914) 388-0800 | Richard B Weininger, MD 125 Millbrook Road, Hudson, NY 12534 Ph: (914) 388-0800 |
News Archive
62% of school-age children and 85% of pregnant women in Israel have low iodine intakes, according to the country's first national iodine survey. Government funding and legislation, and a government-regulated program of salt or food iodization, are essential to reducing the deficiency, which poses a high risk of impaired neurological development.
The Multiple Myeloma Research Consortium (MMRC) and Mount Sinai School of Medicine today announced that Mount Sinai has become the newest Member Institution to join the MMRC to accelerate the development of new treatments for multiple myeloma.
A new strategy for emergency anticoagulant treatment for patients with acute myocardial infarction has been put in place by a team led by Philippe-Gabriel Steg at Inserm Unit 698 (Haemostasis, Bioengineering, Immunopathology and Cardiovascular Remodelling), at H-pital Bichat, AP-HP, Universit- Paris Diderot).
Ambit Biosciences Corporation announced today the enrollment and dosing at the University of Texas M. D. Anderson Cancer Center of the first patient in the ACE (AC220 Monotherapy Efficacy) Phase 2 pivotal trial in patients with relapsed or refractory acute myeloid leukemia (AML).
› Verified 6 days ago
Vinita Gupta, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 71 Prospect Ave Ste 210, Hudson, NY 12534 Phone: 518-828-2565 | |
Salim Ghulam Contractor, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 69 Prospect Ave, Hudson, NY 12534 Phone: 518-822-8484 Fax: 518-822-9335 | |
Dr. Ana Lups, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: Rt 14 Box 149, Hudson, NY 12534 Phone: 518-828-3292 Fax: 518-828-7176 | |
Peter Augustus Franklin, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 71 Prospect Ave, Hudson, NY 12534 Phone: 518-751-1016 Fax: 518-751-1020 | |
Vinod K Gupta, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 67 Prospect Ave, Suite 210, Hudson, NY 12534 Phone: 518-828-2565 | |
Carl D Atkins, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 69 Prospect Ave, Hudson, NY 12534 Phone: 518-822-8484 |